CNPAX
Price
$73.30
Change
+$0.37 (+0.51%)
Updated
Dec 3 closing price
Net Assets
162.64B
JDWNX
Price
$130.31
Change
+$0.17 (+0.13%)
Updated
Dec 3 closing price
Net Assets
4.5B
Interact to see
Advertisement

CNPAX vs JDWNX

Header iconCNPAX vs JDWNX Comparison
Open Charts CNPAX vs JDWNXBanner chart's image
American Funds New Perspective 529A
Price$73.30
Change+$0.37 (+0.51%)
VolumeN/A
Net Assets162.64B
Janus Henderson Global Research N
Price$130.31
Change+$0.17 (+0.13%)
VolumeN/A
Net Assets4.5B
CNPAX vs JDWNX Comparison Chart in %
View a ticker or compare two or three
VS
CNPAX vs. JDWNX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPAX is a Buy and JDWNX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPAX has more cash in the bank: 163B vs. JDWNX (4.5B). JDWNX pays higher dividends than CNPAX: JDWNX (0.75) vs CNPAX (0.46). CNPAX was incepted earlier than JDWNX: CNPAX (24 years) vs JDWNX (8 years). CNPAX (0.77) is less costly to investors than JDWNX (0.62). JDWNX is a more actively managed with annual turnover of: 28.00 vs. CNPAX (24.00). CNPAX has a lower initial minimum investment than JDWNX: CNPAX (250) vs JDWNX (1000000). CNPAX annual gain was more profitable for investors over the last year : 11.91 vs. JDWNX (9.03). JDWNX return over 5 years is better than : 37.21 vs. CNPAX (25.34).
CNPAXJDWNXCNPAX / JDWNX
Total Expense Ratio0.770.62124%
Annual Report Gross Expense Ratio0.770.62124%
Fund Existence24 years8 years-
Gain YTD20.10520.112100%
Front Load4%N/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets163B4.5B3,621%
Annual Yield % from dividends0.460.7561%
Returns for 1 year11.919.03132%
Returns for 3 years46.1054.5085%
Returns for 5 years25.3437.2168%
Returns for 10 years101.99N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTNM11.120.63
+6.01%
Contineum Therapeutics
LOB33.281.11
+3.45%
Live Oak Bancshares
ALSN90.521.20
+1.34%
Allison Transmission Holdings
ATMVU7.75N/A
N/A
AlphaVest Acquisition Corp
CTSO0.73-0.04
-4.67%
Cytosorbents Corp